Zacks.com featured highlights Nutex, RCM, Remitly and Belden

Remitly (RELY) reported Q2 2026 results with record revenue, adjusted EBITDA, and net income, and raised its full-year outlook. Active customers reached 10.2 million, up 20% YoY. Adjusted EBITDA grew 79% YoY to $114.7 million, while revenue increased 20% to $495.2 million. However, net income included a one-time $140.6 million tax benefit, and the take rate may be declining.

Remitly Global (RELY) shares rose 17.4% in August, reaching a 52-week high. Q2 2026 earnings showed 27% growth in send volume to $23.5B, 20% revenue growth to $495M, and 20% active customer growth to 10.2M. Operating margin hit 13.5%. The company expects revenue to reach nearly $2B this year, with potential for 15% annual growth and expanding profit margins.

Allient (ALNT) reported Q2 revenue of $153.8M, up 10.2% YoY, beating estimates by 5.5%. The company's stock is flat since reporting. Advanced Energy (AEIS) saw 30% YoY revenue growth, outperforming expectations by 5.6%, but its stock fell 6.1%. nLIGHT (LASR) reported 33.8% YoY revenue growth, beating estimates by 4.6%, but its stock dropped 44%. Belden (BDC) reported 11.6% YoY revenue growth, in line with expectations, and its stock rose 12.5%. Bel Fuse (BELF.A) saw 25.2% YoY revenue growth, bea

LendingTree (TREE) reported $313.4M in Q2 revenue, up 25.3% YoY but missing estimates by 0.7%. Its stock fell 22.3% post-earnings. Robinhood (HOOD) saw $1.31B in revenue, up 32.3% YoY, beating estimates by 1.8%, and its stock rose 23.8%. Coinbase (COIN) reported $1.22B in revenue, down 18.5% YoY, missing estimates by 5.9%, yet its stock rose 13.6%. Remitly (RELY) reported $495.2M in revenue, up 20.2% YoY, beating estimates by 1.8%, and its stock rose 9.9%.

Nutex Health (NASDAQ: NUTX) commented on a Fifth Circuit ruling invalidating federal QPA calculation rules under the No Surprises Act, which the company says artificially deflated payments. The court ruled insurers cannot include non-negotiated 'ghost rates' and must include bonus payments in QPA calculations. Nutex Health expects this to lead to fairer upfront payments for providers. The ruling may impact the company's financials, but the timeline for new regulations is uncertain.

Belden (NYSE: BDC) reported record Q2 revenue of $750.2M, up 11.6% YOY, and net income of $68.5M, up 12.3%. The company benefits from AI data center demand and completed a $1.85B acquisition of RUCKUS Networks. Analysts rate it a Buy with an average price target of $156.25, implying 20% upside. Risks include competition and integration challenges.